Income Statement Astal Laboratories Limited

Stocks

MACINTR

INE307N01014

Pharmaceuticals

Market Closed - Bombay S.E. 03:32:31 01/10/2026 pm IST			5-day change	1st Jan Change
69.54 ^INR	-1.93%		-0.66%	-19.93%

14/08	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
30/05	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

08d8ff4f981ded1e.rxEVIFVw9MnHXzEZFzOMS2-i7GhIIoZq9hkDZTu4Eks.6WJjVDdGta6TOX5gR1fCfxWVpzcRD85cjn1mM1XycQHgPHZjbQiao4tmVg

Published financial data: ASTAL LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Interest and Dividend Income, Total	21.08L	17.87L	-	-	-
Interest Expense, Total	-	-	-	70.07L	1.71Cr
Net Interest Income	21.08L	17.87L	-	-70.07L	-1.71Cr
Other Revenues, Total	-	3.43Cr	24Cr	64Cr	250.35Cr
Revenues Before Provison For Loan Losses	21.08L	3.61Cr	24Cr	64Cr	248.64Cr
Total Revenues	21.08L	3.61Cr	24Cr	64Cr	248.64Cr
Salaries And Other Employee Benefits	9L	6L	-	1.34Cr	5.02Cr
Cost of Services Provided, Total	1L	3.38Cr	23Cr	48Cr	220.69Cr
Depreciation & Amortization - (IS) - (Collected)	1L	79T	3L	22.31L	1.23Cr
Other Operating Expenses	11.18L	12.29L	-	1.7Cr	3.99Cr
Total Operating Expenses	22.28L	3.57Cr	23Cr	52Cr	230.93Cr
Operating Income	-1L	3L	1.09Cr	12Cr	18Cr
Currency Exchange Gains (Loss)	-	-	-	-	2L
Other Non Operating Income (Expenses)	-	-1T	-	-1T	-2T
EBT, Excl. Unusual Items	-1L	3L	1.09Cr	12Cr	18Cr
Gain (Loss) on Sale of Assets	-50.3T	-	-	-	-
EBT, Incl. Unusual Items	-2L	3L	1.09Cr	12Cr	18Cr
Income Tax Expense	500	2L	30.19L	3.05Cr	3.02Cr
Earnings From Continuing Operations	-2L	2L	78.47L	8.93Cr	15Cr
Net Income to Company	-2L	2L	78.47L	8.93Cr	15Cr
Net Income - (IS)	-2L	2L	78.47L	8.93Cr	15Cr
Net Income to Common Incl Extra Items	-2L	2L	78.47L	8.93Cr	15Cr
Net Income to Common Excl. Extra Items	-2L	2L	78.47L	8.93Cr	15Cr
Per Share Items
Net EPS - Basic	-0.04	0.04	1.55	9.08	8.62
Basic EPS - Continuing Operations	-0.04	0.04	1.55	9.08	8.62
Basic Weighted Average Shares Outstanding	39.74L	39.74L	50.51L	98.3L	1.71Cr
Net EPS - Diluted	-0.04	0.04	1.55	8.04	7.81
Diluted EPS - Continuing Operations	-0.04	0.04	1.55	8.04	7.81
Diluted Weighted Average Shares Outstanding	39.74L	39.74L	50.51L	1.11Cr	1.88Cr
Normalized Basic EPS	-0.02	0.05	1.34	7.62	6.49
Normalized Diluted EPS	-0.02	0.05	1.34	6.75	5.88
Supplemental Items
Total Revenues (As Reported)	21.08L	3.61Cr	-	64Cr	250.37Cr
Effective Tax Rate - (Ratio)	-0.29	48.75	27.78	25.48	17.04
Total Current Taxes	40T	96T	29.37L	2.94Cr	2.68Cr
Total Deferred Taxes	-39.5T	60T	82T	11.14L	34.05L
Normalized Net Income	-75.19T	2L	67.91L	7.49Cr	11Cr
Non-Cash Pension Expense	26.8T	2L	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	2L	8L	6.08Cr	1.73Cr	70.27L
Long-Term Investments - (FS Template)	-	-	-	-	3.44Cr
Loans and Lease Receivables - (FS Template)	5.11Cr	3.79Cr	3.99Cr	4.09Cr	4.15Cr
Other Receivables	-	3.17Cr	16Cr	28Cr	156.96Cr
Gross Property Plant And Equipment	8L	8L	79.43L	12Cr	68Cr
Accumulated Depreciation	-7L	-7L	-10.43L	-32.75L	-5.35Cr
Net Property Plant And Equipment	1L	56T	69L	11Cr	63Cr
Goodwill	-	-	-	-	203.2Cr
Other Intangibles, Total	-	-	-	-	1.37Cr
Other Current Assets, Total	2L	2.86Cr	4.84Cr	16Cr	85Cr
Deferred Tax Assets Long-Term (Collected)	70.9T	10T	-	-	-
Other Long-Term Assets, Total	6L	1T	5.2Cr	2.16Cr	39.67L
Total Assets	5.23Cr	9.91Cr	37Cr	63Cr	518.74Cr
Liabilities
Accounts Payable, Total	-	3.79Cr	12Cr	11Cr	124.35Cr
Accrued Expenses, Total	10.2T	4L	5L	4L	2.11Cr
Short-Term Borrowings	-	-	-	13Cr	29Cr
Current Portion of Long-Term Debt	-	-	5L	11.81L	1.48Cr
Current Portion of Leases	-	-	-	-	16.21L
Long-Term Debt	-	-	25.74L	45.61L	19Cr
Long-Term Leases	-	-	-	-	64.78L
Current Income Taxes Payable	-	-	38.18L	3.13Cr	7.24Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	89.59L	1Cr	1L	53.38L
Pension & Other Post Retirement Benefits	6L	-	-	-	-
Deferred Tax Liability Non-Current	-	-	72T	11.86L	86.24L
Other Non Current Liabilities	42.3T	-	-	-	-1T
Total Liabilities	7L	4.73Cr	13Cr	27Cr	184.99Cr
Common Stock, Total	3.97Cr	3.97Cr	9.83Cr	9.83Cr	42Cr
Additional Paid In Capital	-	-	12Cr	12Cr	263.85Cr
Retained Earnings	97.83L	99.46L	1.78Cr	11Cr	25Cr
Comprehensive Income and Other	20.8L	20.81L	20.8L	3.94Cr	2.28Cr
Total Common Equity	5.16Cr	5.18Cr	23Cr	36Cr	333.76Cr
Total Equity	5.16Cr	5.18Cr	23Cr	36Cr	333.76Cr
Total Liabilities And Equity	5.23Cr	9.91Cr	37Cr	63Cr	518.74Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	39.74L	39.74L	98.3L	98.3L	4.22Cr
ECS Total Common Shares Outstanding	39.74L	39.74L	98.3L	98.3L	4.22Cr
Book Value / Share	12.99	13.03	23.74	36.62	79.06
Tangible Book Value	5.16Cr	5.18Cr	23Cr	36Cr	129.19Cr
Tangible Book Value Per Share	12.99	13.03	23.74	36.62	30.6
Total Debt	0	0	31.22L	13Cr	50Cr
Net Debt	-2L	-8L	-5.76Cr	12Cr	49Cr
Full Time Employees	-	-	-	-	22

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	-2L	2L	78.47L	8.93Cr	15Cr
Depreciation, Depletion & Amortization	1L	79T	3L	22.31L	1.2Cr
Total Depreciation, Depletion & Amortization	1L	79T	3L	22.31L	1.2Cr
Amortization of Deferred Charges, Total	-	-	-	-	3L
Change In Inventories	-	-	-1.06Cr	-14Cr	-5.89Cr
Change in Accounts Payable	-6L	3.79Cr	7.72Cr	-74.03L	45Cr
Change in Other Net Operating Assets (Collected)	3L	-5.08Cr	-13Cr	-11Cr	-63Cr
Other Operating Activities	-21.08L	-17.27L	25.85L	3.33Cr	-10Cr
Cash from Operations	-24.88L	-1.44Cr	-5.59Cr	-13Cr	-18Cr
Capital Expenditure	-	-	-5.92Cr	-5.78Cr	-1.39Cr
Sale of Property, Plant, and Equipment	3L	-	-	-	-
Cash Acquisitions	-	-	-	-	-29.63L
Investment in Marketable and Equity Securities, Total	-	-	-	-2.06Cr	-77.28L
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-20.5L	-10L	-
Other Investing Activities, Total	21.08L	17.87L	1L	12.52L	29.16L
Cash from Investing	23.58L	17.87L	-6.11Cr	-7.81Cr	-2.17Cr
Long-Term Debt Issued, Total	-	1.32Cr	32.96L	31.67L	-
Total Debt Issued	-	1.32Cr	32.96L	31.67L	-
Long-Term Debt Repaid, Total	-	-	-2L	-5L	-1.66Cr
Total Debt Repaid	-	-	-2L	-5L	-1.66Cr
Issuance of Common Stock	-	-	17Cr	-	-
Other Financing Activities, Total	-	-	-	3.03Cr	4.24Cr
Cash from Financing	-	1.32Cr	18Cr	3.29Cr	2.58Cr
Miscellaneous Cash Flow Adjustments	-	1T	-	-	-
Net Change in Cash	-1L	7L	5.99Cr	-17Cr	-17Cr
Supplemental Items
Cash Interest Paid	-	-	-	70.07L	1.94Cr
Cash Income Tax Paid (Refund)	500	96T	3L	30.13L	1.02Cr
Net Debt Issued / Repaid	-	1.32Cr	31.22L	26.2L	-1.66Cr

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	-0.32	0.22	3.37	17.86	5.05
Return On Equity %	-0.33	0.32	5.5	30.08	7.96
Return on Common Equity	-0.33	0.32	5.5	30.08	7.96
Margin Analysis
Gross Profit Margin %	100	6.99	5.57	24.22	11.4
SG&A Margin	45.78	2.48	0.85	2.39	2.17
Income From Continuing Operations Margin %	-8.12	0.45	3.32	14.02	5.92
Net Income Margin %	-8.12	0.45	3.32	14.02	5.92
Net Avail. For Common Margin %	-8.12	0.45	3.32	14.02	5.92
Normalized Net Income Margin	-3.57	0.55	2.87	11.76	4.46
Asset Turnover
Asset Turnover	0.04	0.48	1.02	1.27	0.85
Short Term Liquidity
Current Ratio	5.05T	2.09	2.36	1.86	1.5
Quick Ratio	5.03T	1.49	1.99	1.25	0.98
Operating Cash Flow to Current Liabilities	-243.93	-0.3	-0.43	-0.47	-0.11
Long Term Solvency
Total Debt/Equity	-	-	1.34	36.86	14.95
Total Debt / Total Capital	-	-	1.32	26.93	13
LT Debt/Equity	-	-	1.1	1.27	5.78
Long-Term Debt / Total Capital	-	-	1.09	0.93	5.03
Total Liabilities / Total Assets	1.32	47.75	36.25	43.17	35.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.79	1.61T	556.01	169.15	290.08
Gross Profit, 1 Yr. Growth %	3.79	19.64	1.36T	567.15	82.75
Earnings From Cont. Operations, 1 Yr. Growth %	-384.22	-195.91	4.68T	1.04T	64.81
Net Income, 1 Yr. Growth %	-384.22	-195.91	4.68T	1.04T	64.81
Normalized Net Income, 1 Yr. Growth %	-248.33	-366.67	3.3T	1T	48.03
Diluted EPS Before Extra, 1 Yr. Growth %	-384.22	-195.29	3.69T	417.71	-2.86
Common Equity, 1 Yr. Growth %	-0.31	0.32	350.85	54.22	827.24
Total Assets, 1 Yr. Growth %	-1.48	89.47	269.53	73	718.97
Tangible Book Value, 1 Yr. Growth %	-0.31	0.32	350.85	54.22	258.91
Cash From Operations, 1 Yr. Growth %	33.57	477.45	289.09	124.35	41.39
Capital Expenditures, 1 Yr. Growth %	-	-	-	-2.39	-75.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.18	321.43	959.45	320.1	224.24
Gross Profit, 2 Yr. CAGR %	2.18	11.44	150.09	1.21T	250.14
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.04	65.05	577.41	2.23T	332.96
Net Income, 2 Yr. CAGR %	-22.04	65.05	577.41	2.23T	332.96
Normalized Net Income, 2 Yr. CAGR %	-34.59	98.64	851.58	1.83T	303.95
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.04	64.52	500.88	1.3T	124.21
Common Equity, 2 Yr. CAGR %	-0.1	0.01	112.67	163.69	278.15
Total Assets, 2 Yr. CAGR %	-0.4	36.63	164.61	152.84	276.41
Tangible Book Value, 2 Yr. CAGR %	-0.1	0.01	112.67	163.69	135.27
Cash From Operations, 2 Yr. CAGR %	11.95	177.72	374.01	195.17	78.11
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-51.48
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-10.98	161.42	388.42	570.9	310.03
Gross Profit, 3 Yr. CAGR %	-10.98	7.7	86.55	318.21	580.27
Earnings From Cont. Operations, 3 Yr. CAGR %	-40.72	-16.48	407.03	705.15	864.38
Net Income, 3 Yr. CAGR %	-40.72	-16.48	407.03	705.15	864.38
Normalized Net Income, 3 Yr. CAGR %	-45.76	4.41	411.7	899.37	721.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-41.03	-16.66	368.09	471.77	475.38
Common Equity, 3 Yr. CAGR %	-0.24	0.04	65.21	91.07	300.98
Total Assets, 3 Yr. CAGR %	-0.64	23.41	90.36	129.66	274.1
Tangible Book Value, 3 Yr. CAGR %	-0.24	0.04	65.21	91.07	192.23
Cash From Operations, 3 Yr. CAGR %	-6.07	93.43	210.75	269.16	130.95
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-7.1	64.54	139.74	216.04	314.55
Gross Profit, 5 Yr. CAGR %	-7.1	-3.35	34.57	138.01	168.49
Earnings From Cont. Operations, 5 Yr. CAGR %	26.98	19.96	57.06	216.39	375.99
Net Income, 5 Yr. CAGR %	26.98	19.96	57.06	216.39	375.99
Normalized Net Income, 5 Yr. CAGR %	2.41	46.9	70.51	235.65	365.52
Diluted EPS Before Extra, 5 Yr. CAGR %	33.91	15.44	49.22	157.65	248.71
Common Equity, 5 Yr. CAGR %	-0.48	-0.4	35.03	47.42	130.08
Total Assets, 5 Yr. CAGR %	-0.66	12.87	47.02	64.42	150.04
Tangible Book Value, 5 Yr. CAGR %	-0.48	-0.4	35.03	47.42	90.3
Cash From Operations, 5 Yr. CAGR %	-3.88	37.84	79.47	129.06	148.63